Patents for C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120) |
---|
09/07/2006 | DE102005009909A1 Verbindungen geeignet zur Beseitigung fehlgefalteter Proteine Compounds suitable for the removal of misfolded proteins |
09/06/2006 | EP1698629A2 Polyamines and their use in therapy |
09/06/2006 | CN1827733A Organic electroluminescence device |
08/30/2006 | EP1373250B1 Viologen linked acridine based molecule and process for the preparation thereof |
08/29/2006 | US7097995 Chemiluminescent acridinium compounds and analogues thereof as substrates of hydrolytic enzymes |
08/23/2006 | EP1278747B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
08/23/2006 | CN1271167C Organic electroluminescent element |
08/17/2006 | US20060183905 Derivatives of 4-(thio-or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
08/16/2006 | EP1689705A2 Fused ring dicationic anti-protozoan agents and their prodrugs |
08/16/2006 | EP1397488B1 Novel compounds for chemiluminescense procedures |
08/09/2006 | EP1687275A1 Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain |
08/09/2006 | EP1177197B1 Polyamines and their use in therapy |
08/01/2006 | US7083986 Acridinium compound for use in the concurrent detection of target analytes in immunoassays or nucleic acid assays |
07/26/2006 | EP1532089A4 Fluorene compound and organic luminescent device using the same |
06/29/2006 | US20060142323 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease |
06/27/2006 | CA2326710C New dihydrofuro-¬3,4-b|quinolein-1-ones derivatives, the procedure for preparing them and the pharmaceutical compositions that contain them |
06/22/2006 | US20060134425 Organic luminescence device (OLED) containing both a 5,5'-spirobi(dibenzosilole) compound and a diarylaminofluorene compound; spiro compounds have improved electron-transporting property, luminescence, and durability |
06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
06/06/2006 | US7056912 Heteroaryl derivatives and their use as medicaments |
05/31/2006 | EP1660473A2 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
05/25/2006 | US20060111389 Therapeutic acridone and acridine compounds |
05/18/2006 | WO2006051489A1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases |
05/18/2006 | CA2585983A1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases |
05/10/2006 | CN1255365C Fluorene compound and organic lumnescent device using the same |
05/03/2006 | CN1768038A Using alkylmetal reagents for directed metalation of azaaromatics |
05/02/2006 | US7037642 Removing compounds from blood products with porous particles immobilized in a matrix |
04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
04/20/2006 | US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands |
04/19/2006 | CN1252052C Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
04/11/2006 | US7026310 Heteroaryl derivatives and their use as medicaments |
04/11/2006 | CA2162382C Intercalators having affinity for dna and methods of use |
04/04/2006 | US7022855 Halogen-substituted quinoline derivatives and ectoparasite control agent |
04/04/2006 | CA2235765C Azulenyl nitrone spin trapping agents, methods of making and using same |
03/30/2006 | WO2006034036A1 Fluorescent dye compounds, conjugates and uses thereof |
03/30/2006 | CA2581174A1 Fluorescent dye compounds, conjugates and uses thereof |
03/29/2006 | CN1247704C Method for dyeing or printing of fibre materials and three-colour dye mixture |
03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
03/23/2006 | DE112004000832T5 Lichtemittierende Polymerzusammensetzung Light-emitting polymer composition |
03/22/2006 | CN1751024A Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same |
03/14/2006 | CA1341498C Polysubstituted aryl acridinium esters |
03/09/2006 | US20060051811 Site-specific labelling of proteins using acridone and quinacridone lifetime dyes |
03/08/2006 | EP1353908B1 Processes and synthetic intermediates for preparing n-arylacridancarboxylic acid derivatives |
03/08/2006 | EP0877735B1 Polycyclic compounds |
03/08/2006 | CN1745066A Enzyme substrates, culture media containing same and use thereof in order to detect aminopeptidase activity and/or differentiate gram-positive bacteria from gram-negative bacteria |
02/23/2006 | US20060040900 R(-)-10-methoxy-11-O-acetyl-N-n-propyl-noraporphine; Parkinson's disease, sexual dysfunction, and depressive disorders |
02/16/2006 | US20060035306 Used to detect aminopeptidase activity in microorganisms or to determine whether at least one bacterium belongs to the Gram-positive group or to the Gram-negative group according to the color |
02/14/2006 | US6998405 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
02/09/2006 | US20060030605 Pharmaceutical compounds |
02/09/2006 | US20060030565 Amide derivatives and nociceptin antagonists |
02/07/2006 | US6994980 Chemiluminescent compounds and use thereof |
02/02/2006 | US20060024523 Organic electroluminescence device |
02/01/2006 | CN1239486C Acridine derivative and its application |
01/26/2006 | US20060020141 Colorant compounds |
01/17/2006 | US6987120 Pharmaceutical compounds |
01/11/2006 | EP1613322A2 Aminoquinoline compounds |
01/10/2006 | CA2268157C Acridone derivatives and method of preparation of 8-hydroxy imidazoacridinone derivatives |
01/10/2006 | CA2186618C Novel aryl-n-alkylacridanthiocarboxylate derivatives useful for chemiluminescent detection |
01/10/2006 | CA2184612C Novel aryl n-alkylacridancarboxylate derivatives useful for chemiluminescent detection |
01/04/2006 | EP1611102A2 Using alkylmetal reagents for directed metalation of azaaromatics |
01/04/2006 | EP1169298B1 Pharmaceutical compounds |
01/03/2006 | CA2185350C Acridone-derived bisintercalators as chemotherapeutic agents |
12/29/2005 | US20050288522 Process for preparing pentacene derivatives |
12/22/2005 | WO2005121073A1 Inhibitors of histone deacetylase |
12/21/2005 | EP1322670B1 Electrochemiluminescence from acridan compounds |
12/13/2005 | US6974877 Such as 1,4,8,11-tetramethylpentacene by reacting substituted bis(benzyl)phthalic acid with trifluoromethanesulfonic acid |
12/07/2005 | CN1230416C Pharmaceutical compounds |
11/30/2005 | EP1098864B9 Method for hydrogenating unsaturated heterocyclic compounds |
11/30/2005 | CN1703403A Metabotropic glutamate receptor antagonists |
11/30/2005 | CN1703220A Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease |
11/24/2005 | US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger |
11/17/2005 | US20050255528 Amine-reactive quaternary acridinium compounds, e.g., pentafluorophenyloxy-1-carbonyl-4,7,10,13-tetraoxapentadecyl-(15-amino)-3'-sulfonyl-2',6'-dimethylphenyl-N-(3-sulfopropyl)-acridinium-9-carboxylate with increased solubility; chemiluminescent conjugates, especially with antibodies; assay kits |
11/16/2005 | EP0977738B1 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer |
11/09/2005 | EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity |
11/03/2005 | US20050245523 Heteroaryl derivatives and their use as medicaments |
11/02/2005 | EP1159261B1 Antizyme modulators and their use |
10/27/2005 | WO2004069804A8 Enzyme substrates, culture media containing same and use thereof in order to detect aminopeptidase activity and/or differentiate gram-positive bacteria from gram-negative bacteria |
10/27/2005 | US20050236974 Condensed polycyclic compound and organic light-emitting device using the same |
10/26/2005 | EP1587793A1 Enzyme substrates, culture media containing same and use thereof in order to detect aminopeptidase activity and/or differentiate gram-positive bacteria from gram-negative bacteria |
10/20/2005 | US20050233943 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases |
10/19/2005 | EP1019379B1 Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein |
10/19/2005 | CN1683338A Process for preparing N-methyl quinoline codide compounds by ester reaction solvent |
10/06/2005 | US20050222167 Amidation of 3-(acidinylamino)-5-methylolanilines with 5-[4-phenylpiperazin-1-yl(thio)carbonylamino]nicotinic acids and the product, which have antitumor activity and low toxicity. |
10/06/2005 | US20050221390 High quantum yield acridinium compounds and their uses in improving assay sensitivity |
10/04/2005 | US6951713 Absorbing pathogen-inactivating compounds with porous particles immobilized in a matrix |
10/04/2005 | CA2146763C Quinolone and acridinone derivatives for the treatment of urinary incontinence |
09/22/2005 | US20050209273 Neuroprotectants, analgesics or anticonvulsants |
09/14/2005 | EP1049933B1 Measurement of hydride using chemiluminescent acridinium compounds |
09/07/2005 | EP1539702A4 Hydrophilic chemiluminescent acridinium labeling reagents |
09/01/2005 | US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
08/30/2005 | US6936615 Heteroaryl derivatives and their use as medicaments |
08/24/2005 | CN1658724A Luminescent element material and luminescent element comprising the same |
08/11/2005 | US20050176744 nitrogen heterocyclyl-(thio)carbonyl- quinoline derivatives used for treating cervical carcinoma or ovarian adenocarcinoma |
08/04/2005 | WO2004091485A3 Aminoquinoline compounds |
08/03/2005 | EP1558255A2 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease |
08/02/2005 | US6924154 Hydrophilic chemilumescent acridinium labeling reagents |
07/28/2005 | WO2005051296A3 Fused ring dicationic anti-protozoan agents and their prodrugs |
07/28/2005 | US20050165044 Use against Trypanosoma brucei rhodesiense (T.b.r.) and Plasmodium falciparum; prodrugs of these compounds can be used as oral treatment for malaria and human African trypanosomiasis; 2,7-bis-guanidino-9H-fluorene, 2,7-bis-guanidinofluoren-9-one |
07/21/2005 | WO2005043124A3 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors |
07/21/2005 | US20050158815 High speed signal generation; storage stability |
07/20/2005 | EP1185493B1 Quinones for treatment of diseases |